{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:01:38Z","timestamp":1792033298281,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jiph.2022.01.005","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T21:11:36Z","timestamp":1642713096000},"page":"285-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["A systematic review of Ebola virus disease outbreaks and an analysis of the efficacy and safety of newer drugs approved for the treatment of Ebola virus disease by the US Food and Drug Administration from 2016 to 2020"],"prefix":"10.1016","volume":"15","author":[{"given":"Palanisamy","family":"Sivanandy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pee Hui","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai Weng","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ng Sin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Foo Kar","family":"Mun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestine Ang Jia","family":"Yii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charissa Cheah Xiao","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2022.01.005_bib1","unstructured":"World Health Organization. Ebola virus disease. WHO. Available on: \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ebola-virus-disease\u3009 (accessed on 28 December 2020)."},{"key":"10.1016\/j.jiph.2022.01.005_bib2","unstructured":"Centers for Disease Control and Prevention. 2014\u20132016 Ebola Outbreak in West Africa. Available on: \u3008https:\/\/www.cdc.gov\/vhf\/ebola\/about.html\u3009 (accessed on 28 December 2020)."},{"issue":"5656","key":"10.1016\/j.jiph.2022.01.005_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.1092528","article-title":"Multiple Ebola virus transmission events and rapid decline of central African wildlife","volume":"303","author":"Leroy","year":"2004","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.jiph.2022.01.005_bib4","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1517\/13543784.15.12.1523","article-title":"Progress towards the treatment of Ebola haemorrhagic fever","volume":"15","author":"Str\u00f6her","year":"2006","journal-title":"Expert Opin Invest Drugs"},{"issue":"10","key":"10.1016\/j.jiph.2022.01.005_bib5","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41564-018-0227-2","article-title":"The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses","volume":"3","author":"Goldstein","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jiph.2022.01.005_bib6","unstructured":"Centers for Disease Control and Prevention. History of Ebola outbreaks. Available on: \u3008https:\/\/www.cdc.gov\/vhf\/ebola\/history\/2014\u20132016-outbreak\/index.html#:~:text=The%20impact%20\u3009 (accessed on 28 December 2020)."},{"key":"10.1016\/j.jiph.2022.01.005_bib7","unstructured":"World Health Organization. Ebola virus disease-Democratic Republic of the Congo. WHO. Available on: \u3008https:\/\/www.who.int\/csr\/don\/18-november-2020-ebola-drc\/en\/\u3009 (accessed on 28 December 2020)."},{"key":"10.1016\/j.jiph.2022.01.005_bib8","unstructured":"Center of Infectious Disease Research and Prevention (CIDRAP). WHO declares end to DRC's 11th Ebola outbreak. Available on: \u3008https:\/\/www.cidrap.umn.edu\/news-perspective\/2020\/11\/who-declares-end-drcs-11th-ebola-outbreak\u3009 (accessed on 28 December 2020)."},{"key":"10.1016\/j.jiph.2022.01.005_bib9","unstructured":"World Health Organization. New Ebola outbreak detected in northwest Democratic Republic of the Congo; WHO surge team supporting the response. WHO. Available on: \u3008https:\/\/www.who.int\/news\/item\/01\u201306-2020-new-ebola-outbreak-detected-in-northwest-democratic-republic-of-the-congo-who-surge-team-supporting-the-response\u3009 (accessed on 16 January 2021)."},{"key":"10.1016\/j.jiph.2022.01.005_bib10","unstructured":"World Health Organization. Ebola Virus Disease Democratic Republic of Congo: External Situation Report 94 \/ 2019. WHO. Available on: \u3008https:\/\/www.who.int\/publications-detail-redirect\/10665\u2013332654\u3009 (accessed on 16 January 2021)."},{"key":"10.1016\/j.jiph.2022.01.005_bib11","unstructured":"Centers for Disease Control and Prevention. History of Ebola Virus Disease (EVD). Available on: \u3008https:\/\/www.cdc.gov\/vhf\/ebola\/history\/chronology.html\u3009 (accessed on 16 January 2021)."},{"issue":"7","key":"10.1016\/j.jiph.2022.01.005_bib12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jiph.2020.03.014","article-title":"Ebola outbreak in West Africa, 2014 - 2016: epidemic timeline, differential diagnoses, determining factors, and lessons for future response","volume":"13","author":"Kamorudeen","year":"2020","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jiph.2022.01.005_bib13","unstructured":"World Health Organization. Ebola virus disease \u2013 Democratic Republic of the Congo. WHO. Available on: \u3008https:\/\/www.who.int\/csr\/don\/04-June-2020-ebola-drc\/en\/\u3009 (accessed on 16 January 2021)."},{"issue":"3","key":"10.1016\/j.jiph.2022.01.005_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jiph.2020.12.030","article-title":"Ebola virus outbreak preparedness plan for developing nations: lessons learnt from affected countries","volume":"14","author":"Gupta","year":"2021","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jiph.2022.01.005_bib15","unstructured":"M\u00e9decins Sans Fronti\u00e8res (MSF) International. DRC\u2019s Ebola outbreak crisis update. Available on: \u3008https:\/\/www.msf.org\/drc-ebola-outbreak-crisis-update\u3009 (accessed on 16 January 2021)."},{"key":"10.1016\/j.jiph.2022.01.005_bib16","unstructured":"World Health Organization. Ebola virus disease \u2013 Democratic Republic of the Congo. WHO. Available on: \u3008https:\/\/www.who.int\/csr\/don\/18-november-2020-ebola-drc\/en\/#:~:text=On%2018%20November%202020%2C%20the,EVD\u3009 (accessed on 16 January 2021]."},{"key":"10.1016\/j.jiph.2022.01.005_bib17","unstructured":"Epidemiology and pathogenesis of Ebola virus disease. UpToDate. Available on: \u3008https:\/\/www-uptodate-com.ezp2.imu.edu.my\/contents\/epidemiology-and-pathogenesis-of-ebola-virus-disease?search=ebola&source=search_result&selectedTitle=3\u201344&usage_type=default&display_rank=3#H450821097\u3009 (accessed on 4 January 2021)."},{"key":"10.1016\/j.jiph.2022.01.005_bib18","unstructured":"Centers for Disease Control and Prevention. Transmission. Ebola virus disease. Available on: \u3008https:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/index.html\u3009 (accessed on 5 January 2021)."},{"issue":"10174","key":"10.1016\/j.jiph.2022.01.005_bib19","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(18)33132-5","article-title":"Ebola virus disease","volume":"393","author":"Malvy","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2022.01.005_bib20","unstructured":"Bray M., Chertow D. Epidemiology and pathogenesis of Ebola virus disease. UpToDate. Available on: \u3008https:\/\/www-uptodate-com.ezp2.imu.edu.my\/contents\/epidemiology-and-pathogenesis-of-ebola-virus-disease?search=ebola&source=search_result&selectedTitle=3\u201344&usage_type=default&display_rank=3#H1\u3009 (accessed on 5 January 2021)."},{"issue":"5","key":"10.1016\/j.jiph.2022.01.005_bib21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3109\/10408363.2016.1160866","article-title":"Laboratory diagnosis of Ebola virus disease and corresponding biosafety considerations in the China Ebola Treatment Center","volume":"53","author":"Huang","year":"2016","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"9","key":"10.1016\/j.jiph.2022.01.005_bib22","first-page":"442","article-title":"Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis","volume":"72","author":"Goeijenbier","year":"2014","journal-title":"Neth J Med"},{"key":"10.1016\/j.jiph.2022.01.005_bib23","unstructured":"Centers for Disease Control and Prevention. Ebola virus disease Information for Clinicians in U.S. Healthcare Settings. Available on: \u3008https:\/\/www.cdc.gov\/vhf\/ebola\/clinicians\/evd\/clinicians.html\u3009 (accessed on 4 January 2021)."},{"key":"10.1016\/j.jiph.2022.01.005_bib24","first-page":"141","article-title":"Ebola virus disease in humans: pathophysiology and immunity","volume":"411","author":"Mu\u00f1oz-Fontela","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"issue":"5","key":"10.1016\/j.jiph.2022.01.005_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.molmed.2006.03.006","article-title":"Ebola virus: unravelling pathogenesis to combat a deadly disease","volume":"12","author":"Hoenen","year":"2006","journal-title":"Trends Mol Med"},{"issue":"6","key":"10.1016\/j.jiph.2022.01.005_bib26","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.aogh.2015.02.005","article-title":"Transmission of ebola virus disease: an overview","volume":"80","author":"Rewar","year":"2014","journal-title":"Ann Glob Health"},{"key":"10.1016\/j.jiph.2022.01.005_bib27","unstructured":"Centers for Disease Control and Prevention. Signs and Symptoms. Ebola Hemorrhagic Fever. Available on: \u3008https:\/\/www.cdc.gov\/vhf\/ebola\/symptoms\/index.html\u3009 (accessed on 4 January 2021)."},{"key":"10.1016\/j.jiph.2022.01.005_bib28","unstructured":"Chertow DS, Bray M., Palmore T. Clinical manifestations and diagnosis of Ebola virus disease. UpToDate. Available on: \u3008https:\/\/www.uptodate.com\/contents\/clinical-manifestations-and-diagnosis-of-ebola-virus-disease\u3009 (accessed on 5 January 2021)."},{"issue":"6","key":"10.1016\/j.jiph.2022.01.005_bib29","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/infdis\/jiv546","article-title":"Monitoring of prognostic laboratory markers in ebola virus disease","volume":"213","author":"Janvier","year":"2016","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.jiph.2022.01.005_bib30","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41587-019-0284-y","article-title":"antibodies best ZMapp in Ebola trial","volume":"37","author":"New","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jiph.2022.01.005_bib31","unstructured":"National Institutes of Health. Study finds Ebola treatment ZMapp holds promise, although results not definitive. Available on: \u3008https:\/\/www.nih.gov\/news-events\/news-releases\/study-finds-ebola-treatment-zmapp-holds-promise-although-results-not-definitive\u3009 (accessed on 23 January 2021)."},{"issue":"15","key":"10.1016\/j.jiph.2022.01.005_bib32","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMoa1604330","article-title":"A randomized, controlled trial of zmapp for ebola virus infection","volume":"375","author":"Davey","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2022.01.005_bib33","unstructured":"US Food and Drug Administration. Drug Trials Snapshots: INMAZEB. Available on: \u3008https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drug-trials-snapshots-inmazeb\u3009 (accessed on 25 January 2021)."},{"issue":"1","key":"10.1016\/j.jiph.2022.01.005_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40265-020-01452-3","article-title":"REGN-EB3: first approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.jiph.2022.01.005_bib35","unstructured":"Highlights of Prescribing Information. INMAZEB. Regeneron Pharmaceuticals Inc. New York. Available on: \u3008https:\/\/www.regeneron.com\/sites\/default\/files\/Inmazeb_FPI.pdf\u3009 2020. (revised October 2020; accessed 24 January 2021)."},{"key":"10.1016\/j.jiph.2022.01.005_bib36","unstructured":"US Food and Drug Administration. FDA Approves Treatment for Ebola Virus. Available on: \u3008https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-approves-treatment-ebola-virus\u3009 (accessed 24 January 2021)."},{"issue":"24","key":"10.1016\/j.jiph.2022.01.005_bib37","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1056\/NEJMe1915350","article-title":"Monoclonal antibody therapy for ebola virus disease","volume":"381","author":"Levine","year":"2019","journal-title":"N Engl J Med"},{"issue":"10174","key":"10.1016\/j.jiph.2022.01.005_bib38","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(19)30036-4","article-title":"Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study","volume":"393","author":"Gaudinski","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2022.01.005_bib39","unstructured":"Chertow DS, Bray M., Palmore TN. Treatment and prevention of Ebola virus disease. UpToDate. Available on: \u3008https:\/\/www-uptodate-com.ezp2.imu.edu.my\/contents\/treatment-and-prevention-of-ebola-virus-disease?search=tretment%20of%20ebola&source=search_result&selectedTitle=1\u201348&usage_type=default&display_rank=1#H3862604619\u3009 (accessed 5 March 2021)."},{"key":"10.1016\/j.jiph.2022.01.005_bib40","unstructured":"World Health Organization. Optimized supportive care for Ebola virus disease: clinical management standard operating procedures. WHO. Available on: \u3008https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/325000\/9789241515894-eng.pdf?sequence=1\u3009 (accessed 5 March 2021)."},{"key":"10.1016\/j.jiph.2022.01.005_bib41","first-page":"115","article-title":"Clinical management of patients with ebola virus disease in high-resource settings","volume":"411","author":"Marshall Lyon","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jiph.2022.01.005_bib42","unstructured":"Koyfman A., Carrie N., Foran MP. Which medications in the drug class antiemetics are used in the treatment of pediatric dehydration? Medscape. Available on: \u3008https:\/\/www.medscape.com\/answers\/801012\u201380861\/which-medications-in-the-drug-class-antiemetics-are-used-in-the-treatment-of-pediatric-dehydration\u3009 (accessed 5 March 2021)."}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034122000065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034122000065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:12:18Z","timestamp":1761750738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034122000065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1876034122000065"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2022.01.005","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of Ebola virus disease outbreaks and an analysis of the efficacy and safety of newer drugs approved for the treatment of Ebola virus disease by the US Food and Drug Administration from 2016 to 2020","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2022.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}